alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                    Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                               18 U.S.C. (S)1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Diametrics Medical, Inc. (the "Company")
on Form 10-K for the year ended December 31, 2003 as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, David B. Kaysen,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. (S)1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

     1.   The Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     2.   The information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.


                                                      /s/ David B. Kaysen
                                                      --------------------------
                                                      David B. Kaysen
                                                      Chief Executive Officer
                                                      March 15, 2004
[Federal Register Volume 81, Number 32 (Thursday, February 18, 2016)]
[Notices]
[Page 8210]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-03235]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Eye Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Eye Institute Special Emphasis 
Panel; NEI Research Project Grant Applications.
    Date: March 10, 2016.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5635 Fishers Lane, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Brian Hoshaw, Ph.D., Scientific Review Officer, 
National Eye Institute, National Institutes of Health, Division of 
Extramural Research, 5635 Fishers Lane, Suite 1300, Rockville, MD 
20892, 301-451-2020, <a href="/cdn-cgi/l/email-protection#472f28342f263025072a262e2b69292e2f69202831"><span class="__cf_email__" data-cfemail="771f18041f160015371a161e1b59191e1f59101801">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.867, 
Vision Research, National Institutes of Health, HHS)

    Dated: February 11, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-03235 Filed 2-17-16; 8:45 am]
 BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
```

[Federal Register Volume 60, Number 29 (Monday, February 13, 1995)]
[Proposed Rules]
[Page 8209]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-3596]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Mine Safety and Health Administration

30 CFR Parts 6, 18, 19, 20, 21, 22, 23, 26, 27, 29, 33, and 35

RIN 1219-AA87

Testing and Evaluation by Nationally Recognized Testing 
Laboratories and Use of Equivalent Testing and Evaluation Requirements

AGENCY: Mine Safety and Health Administration (MSHA), Labor.

ACTION: Notice to extend period for public comment.

-----------------------------------------------------------------------

SUMMARY: Due to requests from the public, the Mine Safety and Health 
Administration (MSHA) is extending the period for public comment 
regarding its proposed rule for testing and evaluation by nationally 
recognized testing laboratories and the use of equivalent testing and 
evaluation requirements.

DATES: Written comments must be received on or before February 21, 
1995.

ADDRESSES: All comments should be sent to Mine Safety and Health 
Administration, Office of Standards, Regulations, and Variances, Room 
631, 4015 Wilson Boulevard, Arlington, Virginia 22203.

SUPPLEMENTARY INFORMATION: On November 30, 1994, MSHA published a 
proposed rule (59 FR 61376) to establish new procedures and 
requirements for testing and evaluation of certain products MSHA 
approves for use in underground mines. The comment period was scheduled 
to end on February 13, 1995.
    In response to requests from the public, MSHA is extending the time 
for commenting on this proposed rule to February 21, 1995. All 
interested members of the mining community are encouraged to submit 
comments prior to that date.

    Dated: February 8, 1995.
J. Davitt McAteer,
Assistant Secretary for Mine Safety and Health.
[FR Doc. 95-3596 Filed 2-10-95; 8:45 am]
BILLING CODE 4510-43-M
```
Exhibit 32





CERTIFICATION   PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT





In connection with the Annual  Report of United Retail Group, Inc. (the Company) on Form 10-K for the period  ended January 28, 2006 as filed with the Securities and Exchange Commission on  the date hereof (the Report), we, Raphael Benaroya, Chief Executive Officer  of the Company, and George R. Remeta, Chief Financial Officer of the Company,  certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the  Sarbanes-Oxley Act, that based on our knowledge:





(1)  The Report fully complies with the requirements of section 13(a) or 15(d) of  the Securities Exchange Act of 1934; and





(2)  The information contained in the Report fairly presents, in all material  respects, the financial condition and results of operations of the Company.





(A signed original of this  written statement required by Section 906 has been provided to the Company and  will be retained by the Company and furnished to the Commission or its staff  upon request.)





|/s/ RAPHAEL    BENAROYA    | 
|-------------------------- | 
|                           | 
|Raphael    Benaroya        | 
|Chief    Executive Officer | 
|April 27,    2006          | 
|                           | 
|/s/ GEORGE    R. REMETA    | 
|                           | 
|George R.    Remeta        | 
|Chief    Financial Officer | 
|April 27,    2006          | 




---
<PAGE>

Exhibit 99.1


                                CERTIFICATION (1)


Pursuant to Section 906 of the Public Company Accounting Reform and Investor
Protection Act of 2002 (18 U.S.C.ss. 1350, as adopted), Anna E. Gluskin, Chief
Executive Officer and President of Generex Biotechnology Corporation (the
"Company"), and Rose C. Perri, Chief Operating Officer of the Company, each
hereby certifies that, to the best of his or her knowledge:

1. The Company's Quarterly Report on Form 10-Q for the period ended January 31,
2003, and to which this Certification is attached as Exhibit 99.1 (the "Periodic
Report") fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and

2. The information contained in the Periodic Report fairly presents, in all
material respects, the financial condition of the Company at the end of the
period covered by the Periodic Report and results of operations of the Company
for the period covered by the Periodic Report.


DATE: June 12, 2003

                              By:           Anna Gluskin
                                  --------------------------------------------
                                  Anna E. Gluskin, Chief Executive Officer
                                  (Principal Executive Officer)



DATE: June 12, 2003

                                By: Rose C. Perri
                                  --------------------------------------------
                                  Rose C. Perri, Chief Operating Officer
                                  (Principal Financial and Accounting Officer)




--------------------------------------------------------------------------------
(1) THIS CERTIFICATION ACCOMPANIES THIS REPORT PURSUANT TO SS. 906 OF THE
SARBANES-OXLEY ACT OF 2002 AND SHALL NOT BE DEEMED "FILED" BY THE COMPANY FOR
PURPOSES OF SECTION 18 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
EXHIBIT
32.2

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of Apria
Healthcare Group Inc. (the company or Apria) on Form 10-K for
the year ended December 31, 2003 as filed with the SEC on the date hereof (the
Report), I, Amin I. Khalifa, Executive Vice President and Chief Financial Officer of the Company,
certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the
Sarbanes-Oxley Act of 2002, that:

|(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and
|--- | -------------------------------------------------------------------------------------------------------------------------------

|(2) | The information contained in the Report fairly presents, in all material
          respects, the financial condition and results of operations of the Company.
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------------

/s/ AMIN I. KHALIFAAmin I. Khalifa
Executive Vice President and Chief Financial OfficerMarch 15, 2004

A signed original of this written statement required by
Section 906 has been provided to Apria and will be retained by Apria and furnished to the
Securities and Exchange Commission or its staff upon request.
EXHIBIT 21.1

LINCARE HOLDINGS INC. ACTIVE SUBSIDIARIES AND

PARTNERSHIPS

DELAWARE CORPORATIONS:



| | 1) | Alpha Respiratory Inc.
| | -- | ----------------------



| | 2) | Gamma Acquisition Inc.
| | -- | ----------------------



| | 3) | Health Care Solutions at Home Inc.
| | -- | ----------------------------------



| | 4) | Home-Care Equipment Network Inc.
| | -- | --------------------------------



| | 5) | Lincare Holdings Inc.
| | -- | ---------------------



| | 6) | Lincare Inc.
| | -- | ------------



| | 7) | Lincare Licensing Inc.
| | -- | ----------------------



| | 8) | Lincare Pharmacy Services Inc.
| | -- | ------------------------------



| | 9) | Lincare Procurement Inc.
| | -- | ------------------------



| | 10) | Med 4 Home Inc.
| | --- | ---------------

DELAWARE LIMITED LIABILITY
COMPANY:



| | 1) | Caring Responders LLC
| | -- | ---------------------



| | 2) | HCS Lancaster LLC
| | -- | -----------------



| | 3) | Lincare Equipment LLC
| | -- | ---------------------



| | 4) | Lincare Leasing LLC
| | -- | -------------------



| | 5) | mdINR, LLC
| | -- | ----------



| | 6) | Medimatics LLC
| | -- | --------------



| | 7) | PulmoRehab LLC
| | -- | --------------

INDIANA CORPORATION:



| | 1) | ConvaCare Services Inc.
| | -- | -----------------------

MICHIGAN LIMITED
LIABILITY COMPANY:



| | 1) | Healthlink Medical Equipment LLC
| | -- | --------------------------------

NEW YORK
CORPORATION:



| | 1) | Lincare of New York Inc.
| | -- | ------------------------
MEMORANDUM OPINION

No. 04-11-00569-CR

IN RE David CEPEDA JONES

Original Mandamus Proceeding1

PER CURIAM

Sitting: Catherine Stone, Chief Justice

Sandee Bryan Marion, Justice

Steven C. Hilbig, Justice

Delivered and Filed: August 24, 2011

PETITION FOR WRIT OF MANDAMUS DENIED

On August 3, 2011, relator filed two petitions for writ of mandamus. The court has 

considered relator’s petitions and is of the opinion that relator is not entitled to the relief sought. 

Accordingly, the petitions for writ of mandamus are DENIED. See TEX. R. APP. P. 52.8(a). 

Additionally, relator filed an Application for Leave to File Petition for Writ of 

Mandamus. No leave is required to file a petition for writ of mandamus in this court. TEX. R.

APP. P. 52. Therefore, relator’s motion for leave to file is DENIED as moot. 

PER CURIAM

DO NOT PUBLISH

 1 This proceeding arises out of Cause No. 887946, in the County Court at Law No. 8, Bexar County, Texas, the 

Honorable Liza Rodriguez presiding, and Cause No. CM-002974, in the 227th Judicial District Court, Bexar 

County, Texas, the Honorable Philip Kazen presiding.
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

January 23, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-3572

Scosche Industries, Inc:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
A.BROWN CLEiÁ F UPREME COURT BY DE CLERX

CLERKOFTHE SUPREME CO RT ELIZAB B W BY:

C,s15. Ill) 1947 IN THE SUPREME COURT OF THE STATE OF NEVADA
No. 84796 

# FILE SEP 9 2022 GLENEAGLES HOMEOWNERS ASSOCIATION, A NEVADA NONPROFIT CORPORATION,

Petitioner, vs. THE EIGHTH JUDICIAL DISTRICT COURT OF THE STATE OF NEVADA, IN AND FOR THE COUNTY OF CLARK;AND THE HONORABLE TARA D. CLARK NEWBERRY, DISTRICT JUDGE, Respondents,

and SATICOY BAY LLC SERIES 3844 BLUE GULL, A NEVADA LIMITED LIABILITY COMPANY;AND NEVADA ASSOCIATION SERVICES, INC.,

Real Parties in Interest. ORDER DISMISSING PETITION Pursuant tothe stipulation oftheparties, and cause appearing, this matter is dismissed. The parties shall bear their own costs and attorney fees. NRAP 42(b).

It is so ORDERED.

SUPREME COURT OF NEVADA CLERK'S ORDER 

## 2_2- -Lez:71cc: Hon. Tara D. Clark Newberry, District Judge Lipson Neilson P.C. Brandon E. Wood Roger P. Croteau & Associates, Ltd. Eighth District Court Clerk

SUPREME COURT

OF NEVADA CLERK'S ORDER (01 1947
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

January 23, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-3203

Brinly Hardy Co:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20. 

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that this particular product is available 

only from China.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

September 17, 2019

RE: Product Exclusion Request Number USTR-2018-0025-2100

GHL International, Inc: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/%2434_Billion_Exclusions_Gr

anted_September.pdf. 

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Joseph Barloon

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

April 12, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-2759

Valeo North America, Inc: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at

https://ustr.gov/sites/default/files/enforcement/301Investigations/Notice_of_Product_Exclusions

_04.15.19.pdf.

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation.

Sincerely,

Stephen P. Vaughn

General Counsel
IN THE SUPREME COURT OF THE STATE OF MONTANA

No. DA 22-0612

STATE OF MONTANA, 

Plaintiff and Appellee, 

v. 

JONAH MICAH WARR,

Defendant and Appellant.

ORDER

Upon consideration of Appellant’s motion for extension of time, 

and good cause appearing,

IT IS HEREBY ORDERED that Appellant is granted an extension 

of time to and including July 5, 2023, within which to prepare, file, and 

serve Appellant’s opening brief on appeal.

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

May 30 2023

05/30/2023

Case Number: DA 22-0612
Exhibit 32.1



Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)





Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Adams Golf, Inc., a Delaware corporation (the "Company"), does hereby certify that:
The Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2007 (the "Periodic Report") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and the information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                        |  | ADAMS GOLF, INC.                     
|----------------------- |  | -------------------------------------
|                        |  |                                      
|Date:  November 6, 2007 |  | By:/S/ OLIVER G. BREWER III          
|                        |  | Oliver G. Brewer, III                
|                        |  | Chief Executive Officer and President
|                        |  | (Principal Executive Officer)        
|                        |  |                                      
|Date:  November 6, 2007 |  | By:/S/ ERIC LOGAN                    
|                        |  | Eric Logan                           
|                        |  | Chief Financial Officer              
|                        |  | (Principal Financial Officer)        





The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the Periodic Report or as a separate disclosure document
A signed original of this written statement required by Section 906 has been provided to Adams Golf, Inc. and will be retained by Adams Golf, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.